Executive Summary
Where the market stands
Malaysia drew 1.84 million healthcare travellers in 2025, generating RM3.34 billion [Malay Mail 2026], up from RM2.72 billion on 1.6 million arrivals in 2024 [MHTC 2025]. Indonesia alone supplies roughly 65% of inbound volume [MIDA 2024]; China, India, Singapore and the UK round out an 80%-of-volume top five [Malay Mail 2026]. The council has declared 2026 the Malaysia Year of Medical Tourism and set a RM12 billion revenue goal for 2030 [MHTC 2025].
The competitive reality
Thailand remains the regional reference brand, drawing 1.4 million-plus international patients across a far larger medical-and-wellness economy [GM Insights 2024]. Malaysia competes on a sharper cost line — IVF near USD 3,000-4,000 a cycle against USD 8,000-12,000 in Thailand [BestClinicAbroad 2025] — plus English-fluent specialists and JCI-accredited care. The risk is a thinning specialist pipeline at 2.3 doctors per 1,000 [FocusMalaysia 2025].
A market that has tripled its revenue base since the rebound
Healthcare-travel revenue climbed from a pandemic trough to RM3.34 billion in 2025, a 21%-plus annual step in the latest year. Volume growth is real, but revenue per traveller — not headcount alone — now carries the trajectory toward the 2030 goal.
Revenue has outpaced arrivals
Arrivals rose 14% to 1.6 million in 2024 while revenue grew 21% to RM2.72 billion [MHTC 2025] — evidence that average treatment value, not just footfall, is lifting. In 2025 the council reported 1.84 million travellers and RM3.34 billion [Malay Mail 2026]. Non-medical spend adds a further layer, averaging roughly RM2,680 per visitor [MHTC 2025].
The 2030 gap is steep but coordinated
Reaching RM12 billion by 2030 [MHTC 2025] implies a compound pace near 29% a year from the 2025 base [Kira estimates] — well above the recent low-20s trend. Closing it requires higher-acuity case mix and capacity additions, not Indonesian volume alone. KIRA models a base case nearer RM8-9 billion absent a step-change in complex-care throughput [Kira estimates].